A new approach to faster, smarter therapeutic development
Revolutionizing Pharmaceutical Research with Machine Learning
We’re a new approach to a timeless problem
The Problem VS THE SOLUTION
The traditional process of developing new medicines is slow and expensive, taking around 12 years and costing an average of $2.5 billion.
We saw an opportunity to do it better.
Our proprietary technique, iMilkWay, cuts through this complexity. By intelligently selecting the most promising compounds, we’ve compressed the development timeline to approximately 5.5 years and reduced the cost to around $300 million.
The Science of Precise Discovery
iMilkWay is a powerful machine-learning technique for virtual screening of vast databases. Instead of the costly and time-consuming process of physical screening, iMilkWay analyzes millions of compounds digitally to find the most promising candidates.
Our method works by identifying the perfect “key” (drug or nutraceutical) to fit a specific “lock” (therapeutic or biological target). This allows us to predict which substances are most likely to have the desired effect, providing a targeted list of proposals for further validation.
iMilkWay has already generated promising proposals of nutraceuticals and drug repurposing candidates for:
- Chronic Myeloid Leukemia
- SARS-CoV-2 (COVID-19)
- Depression
- Migraine
- Obesity
-
Hyperglycemia
-
Hypercholesterolemia
-
Erectile dysfunction
Discover how our technology is changing the future of healthcare
Ready to innovate faster?
Why Partner With Us?
Speed
We strategically accelerate compound selection, with a special focus on drug repurposing, to reduce the time and cost of development.
Accuracy
We provide highly accurate proposals, saving you time and resources.
Data Management
Our technique is particularly effective in handling complex data, including imbalanced datasets—a common challenge in medical research.
Intellectual Capital
We own the patents for our core method, offering a unique and protected service.
Our collaboration for your success
Built on Strategic Partnerships
Our business model is built on strategic partnerships with leading biotech companies and universities. We provide the proposals, and our partners handle the physical validation and registration.
We already partner for essential in vitro/in vivo validation, with IP at the core of our licensing and sales model.
Let’s Build a Healthier Future Together
Whether you’re a biotech firm looking for your next breakthrough or a researcher seeking a powerful new tool, we want to hear from you
Make the DIFFERENCE in the HEALTH MARKET
OUR Team & Founder’s Dream
“Our company was born from a passion for people, guided by science and a vision for change.”
Carmelina Leite
- Inventor of 3 patents
- Co-author of scientific papers
- 10 years in academic/scientific projects
- Skills in the pharmaceutical area
- Participated in the European Institute of Innovation & Technology (EIT) Jumpstarter, with the project SilicRise
- Participated in the Programa de Apoio à Inovação (PAI) of the University of Porto, with the project SilicRise
- Beneficiary of the Program — Vouchers para Startups; Plano de Recuperação e Resiliência
Contacts
Address
Quinta de Belém, Lote 31-A
3510-779 Viseu, Portugal
Phone
(+351) 962 546 586
Call for a national mobile network
E-mail
info@new-approach.ai
